quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:50:03·1106d
SECFiling
Eucrates Biomedical Acquisition Corp. logo

SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.

EUCR· Eucrates Biomedical Acquisition Corp.
Finance
Original source

Companies

  • EUCR
    Eucrates Biomedical Acquisition Corp.
    Finance

Related

  • SEC1082d
    SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
  • SEC1093d
    SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
  • NEWS1108d
    Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
  • SEC1108d
    Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR1108d
    Eucrates Biomedical Acquisition Corp. Announces Liquidation
  • SEC1116d
    Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
  • SEC1121d
    SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
  • SEC1162d
    Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022